TADALAFIL | A209167 | ACCORD HEALTHCARE INC
Highest NADAC/Unit
$0.1721
per ea
Lowest NADAC/Unit
$0.1031
per ea
Brand NDCs
0
Generic NDCs
7
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 16729037210TADALAFIL 20 MG TABLET | $0.1721 | EA | Generic | — | 2026-06-17 |
| 16729037216TADALAFIL 20 MG TABLET | $0.1721 | EA | Generic | — | 2026-06-17 |
| 16729037110TADALAFIL 10 MG TABLET | $0.1673 | EA | Generic | — | 2026-06-17 |
| 16729037116TADALAFIL 10 MG TABLET | $0.1673 | EA | Generic | — | 2026-06-17 |
| 16729036910TADALAFIL 2.5 MG TABLET | $0.1156 | EA | Generic | — | 2026-06-17 |
| 16729037010TADALAFIL 5 MG TABLET | $0.1031 | EA | Generic | — | 2026-06-17 |
| 16729037016TADALAFIL 5 MG TABLET | $0.1031 | EA | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.